This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Active Biotech Ab. Active years: 2006-2010.
Company Filing History:
Years Active: 2006-2010
Title: Dorthe Da Graca Thrige: Innovator in Immunomodulatory Compounds
Introduction
Dorthe Da Graca Thrige is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of immunomodulatory compounds, holding a total of 3 patents. Her work focuses on developing novel heterocyclic compounds that have the potential to treat various medical conditions.
Latest Patents
Dorthe's latest patents include innovative compounds aimed at immunomodulation. One of her notable inventions is related to tetracyclic immunomodulatory compounds. This invention encompasses methods for their preparation, compositions containing these compounds, and their clinical applications for treating conditions such as rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosus, and psoriasis. More specifically, these compounds act as CD80 antagonists, inhibiting the interactions between CD80 and CD28, which is crucial for immune response regulation.
Career Highlights
Dorthe Da Graca Thrige is associated with Active Biotech AB, where she continues to advance her research and development efforts. Her work has been instrumental in exploring new therapeutic avenues for diseases that require immunomodulation.
Collaborations
Dorthe collaborates with esteemed colleagues, including Ian Richard Matthews and Philip Huxley, to further enhance the impact of her research in the field of immunology.
Conclusion
Dorthe Da Graca Thrige is a trailblazer in the development of immunomodulatory compounds, with a focus on innovative solutions for complex medical conditions. Her contributions are paving the way for future advancements in immunotherapy.